28th Apr 2017 13:57
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Michael Raya |
2 | Reason for the notification | |
a) | Position/status | CEO of West-Ward Pharmaceuticals |
b) | Initial notification /Amendment | Amendment |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction | Purchase of 10,272 shares in the Company in compliance with the Company's shareholding requirement. |
c) | Price(s) and volume(s) | Price(s): £18.689 Volume(s): 10,272 |
d) | Aggregated information | Price(s): £18.689Volume(s): 10,272 Total: £191,973.41 |
e) | Date of the transaction | 26 April 2017 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Related Shares:
Hikma Pharmaceuticals